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Abstract 
 
Neurodevelopmental disorders are conditions of the brain function that may affect emotions, learning 
capabilities, memory and the control of the nervous system. Autism spectrum disorders are included in 
this growth impairments group. Their global prevalence has increased substantially (it is estimated that 
around 10 in 1000 people are now affected worldwide) and this has made it an urgent health issue to 
be studied. Autism spectrum disorders have a strong genetic component, with multiple genes usually 
contributing. However, in a minority of cases, disruptions of a single gene can result in disease. The 
forkhead box P subfamily is involved in many developmental and differentiation processes in the lung, 
heart, gut and central nervous system (transcription factor Forkhead box P1, P2 and P4), and are also 
involved in the immune system (transcription factor Forkhead box P3). Disruptions of the 
transcription factor Forkhead box P1 have been linked with autism spectrum disorders and intellectual 
disability. The protein FOXP1 is highly expressed in the cortex, hippocampus, thalamus and striatum 
of the human and mouse brain. Interestingly, the forkhead box P subfamily of proteins must homo- 
and heterodimerise to perform their transcriptional function. FOXP1 and FOXP2, also a member of 
the forkhead box family linked to deficits in language and speech, are both expressed in the striatum 
where they may function cooperatively. They have been show to interact in vivo and human mutations 
in both genes have a common phenotype: expressive language impairment. 
To understand the functions of Foxp1 in the striatum, a region of the basal ganglia implicated in 
motor-skill learning and automatisation of movement (dorsal striatum) and social behaviour (ventral 
striatum), a mouse line with striatal-specific Foxp1 disruption was generated and combined with 
behavioural tasks to examine animals’ behaviour. Immunohistochemistry and western blot techniques 
were performed to examine Foxp1 expression in the neuronal cells of mutant animals and quantify 
protein levels. 
Histological approaches confirmed the generation of a striatal-specific Foxp1 knockdown mouse 
model, which is viable and shows normal body weight development. An overall assessment of motor 
coordination, balance and evaluation of motor-skill learning were studied and no gross motor 
impairment was observed. Striatal-specific Foxp1 knockdown mice also learn and perform sequences 
of lever-presses normally. The sociability and preference for novelty were tested and seemed normal. 
Although the deletion in dorsal striatum was almost complete, which strengthens the motor function 
data, significant amount of Foxp1 protein remained in ventral striatum, which did not allow 
conclusions about the relation between Foxp1 loss and social behaviour. 
To evaluate a possible relation between Foxp1 and Foxp2 genes, a new mouse line with global 
disruption of Foxp1 and Foxp2 was created and showed pronounced motor-skill learning deficits, 
although their body weight development was normal until day 21. Although these data are consistent 
with a cooperative role for Foxp1 and Foxp2 in motor-skill learning, at this stage it is not possible 
dismiss the possibility that we are affecting two pathways that independently contribute to motor-skill 
learning. 
The striatal-specific Foxp1 knockdown line allows to observe some interesting characteristics but 
future studies can be conducted with different tasks and mouse models, for example, using the new 
mouse line with global disruption of Foxp1 and Foxp2 to investigate social deficits or even deleting 
the Foxp1 gene in adulthood with viral injections in the nucleus accumbens to investigate social 
behaviour. 
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Resumo 
 
As desordens do desenvolvimento neuronal são condições da função cerebral que podem afetar as 
emoções, a capacidade de aprendizagem, a memória e o próprio controlo do sistema nervoso. Os 
gânglios basais constituem o grupo de núcleos subcorticais primariamente responsáveis pelo controlo 
motor, pela aprendizagem motora, por executar funções e comportamentos e ainda pelas emoções. 
Disrupções nesta região do cérebro conduzem a várias desordens no movimento e na atividade 
neuronal. As desordens do espectro do autismo, um dos exemplos mais comuns de doenças do 
desenvolvimento neuronal, exibem fenotipicamente uma função intelectual, motora e comportamental 
alterada. A sua prevalência global tem aumentado substancialmente (estima-se que 10 em cada 1000 
indivíduos sejam afetados mundialmente), o que tem enfatizado a urgência do estudo deste problema 
de saúde global. Em Portugal, embora inferior à mundial, a prevalência global da doença é de 0,92 em 
cada 1000 crianças em idade escolar. Algumas diferenças regionais são encontradas nos Açores, onde 
a prevalência é de 1,56 em cada 1000 crianças em idade escolar. O estudo destas doenças emergentes 
é relevante não só ao nível de um possível diagnóstico cada vez mais precoce como ao nível do 
desenvolvimento de novos tratamentos, mais dirigidos e personalizados, que permitam aumentar a 
qualidade de vida dos doentes e a diminuição do custo destas patologias, tanto para a família como 
para a sociedade. 
As doenças do espetro do autismo têm uma forte componente genética, com múltiplos genes 
envolvidos. Embora alguns casos raros de um único gene envolvido estejam já descritos, a hipótese da 
interação de diferentes proteínas parece ser a melhor aceite. Mutações no fator de transcrição da 
família de proteínas de ligação ao DNA, também conhecidas por proteínas forkhead box, bem como 
alterações nos padrões de expressão do gene Foxp1, têm sido associadas às doenças do espetro do 
autismo, nomeadamente na regulação da excitabilidade dos neurónios espinhosos médios, a défices na 
vocalização ultrassónica e a outras patologias que afetam a capacidade intelectual. Todas as funções 
que as proteínas desempenham no cérebro continuam ainda por desvendar.  Sabe-se, no entanto, que 
esta família de proteínas está associada a vários processos cruciais no desenvolvimento e diferenciação 
(fatores de transcrição Foxp1, Foxp2 e Foxp4), bem como a processos envolvidos no sistema 
imunitário (fator de transcrição Foxp3). A proteína FOXP1 é altamente expressa em três regiões do 
cérebro humano e de roedores: córtex, hipocampo e estriado. O gene Foxp1 é regulado pelo gene 
Foxp2, também membro da subfamília de proteínas forkhead box e associado a défices cognitivos na 
linguagem e no discurso. É conhecida a interação entre os dois genes em processos biológicos e o seu 
fenótipo comum, evidenciado essencialmente ao nível de défices na expressão da linguagem. Ambos 
são expressos a partir do dia embrionário 12,5, permanecendo durante a fase adulta. 
Para compreender as funções do gene Foxp1 no estriado, uma região dos gânglios basais que está 
implicada na aprendizagem da sequência motora e na automatização do movimento (zona dorsal do 
estriado) e no comportamento social (zona ventral do estriado), foi realizada uma abordagem de 
supressão do gene especificamente no estriado. Foram realizadas abordagens de imunohistoquímica e 
western blot para visualização da expressão das proteínas ao nível celular e para a sua quantificação 
proteica, respetivamente. A linha de ratinho criada foi submetida a diferentes tarefas comportamentais, 
permitindo observar as microestruturas envolvidas no comportamento animal in vivo, tanto ao nível do 
movimento como do processo de socialização. 
A abordagem histológica confirmou a criação de um modelo de ratinho com diminuição da expressão 
do gene Foxp1 no estriado, que é viável e revela um normal desenvolvimento. A avaliação da 
coordenação motora, do balanço e a avaliação da capacidade de aprendizagem da sequência motora 
mostraram que não existe défice ao nível da função motora quando a expressão do gene é reduzida. A 
linha de ratinho criada também revelou uma capacidade de aprendizagem e performance da sequência 
motora normal. O comportamento social foi estudado, tanto ao nível do processo de socialização como 
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ao nível da preferência pela novidade social após um primeiro contacto com um indivíduo conhecido. 
O modelo animal não evidenciou diferenças significativas nestas abordagens. Apesar da deleção na 
região dorsal do estriado ter sido quase completa, o que fortalece os resultados obtidos no que 
concerne à função motora, a deleção foi apenas substancial na região ventral do estriado, o que não 
permite concluir com este modelo acerca da relação da perda de função da proteína e o 
comportamento social. 
De modo a avaliar uma possível interação entre os genes Foxp1 e Foxp2, uma nova linha transgénica 
de ratinho foi criada, na qual foi introduzida uma disrupção global de ambos os fatores de transcrição. 
Este novo modelo revelou interessantes défices ao nível da função motora, apesar do seu 
desenvolvimento ser normal até aos 21 dias de idade. Apesar destes resultados serem consistentes com 
uma possível cooperação funcional de Foxp1 e Foxp2 na aprendizagem da capacidade motora, não é 
possível eliminar a hipótese deste procedimento poder estar a ser influenciado por duas vias que 
independentemente contribuem para o processo. 
A abordagem com o modelo biológico na qual o gene Foxp1 está especificamente suprimido no 
estriado permitiu observar características interessantes mas estudos futuros poderão ser conduzidos 
com outros modelos e com a utilização de diferentes tarefas comportamentais como, por exemplo, a 
utilização da nova linha de ratinho com a disrupção global de Foxp1 e Foxp2 em tarefas de 
comportamento mais específicas para o processo de interação de diferentes entidades sociais, ou 
mesmo a supressão localizada do gene Foxp1 em regiões específicas do estriado de ratinhos adultos, 
com recurso a técnicas de injeção viral. 
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1. Introduction 
 
1.1. Impact of neurodevelopmental disorders 
According to the World Health Organisation (WHO), neurodevelopmental disorders involve a group 
of conditions with onset in infancy or childhood, characterised by the impairment or delay in functions 
related to the central nervous system formation, development and maturation (World Health 
Organization, Geneva 2013). These disorders may affect a single area of development (specific 
developmental disorders of speech and language, of scholastic skills, and/or motor function) or several 
areas (pervasive developmental disorders and intellectual disability) (World Health Organization, 
Geneva 2013). 
 
1.1.1. Autism spectrum disorders 
The word “autism” was initially used to describe a subset of schizophrenia patients who were 
especially withdrawn and self-absorbed. In 1938 some cases of children with similar symptoms were 
reported but the first cases of “early infantile autism” were only described in 1943 (Kanner 1943). In 
1980, “infantile autism” was listed in the Diagnostic and Statistical Manual of Mental Disorders III 
(DSM III) (American Psychiatric Association 1980), and officially separated from childhood 
schizophrenia. Since then it has come to be recognised as a neurodevelopmental disorder, with varying 
degrees of severity, and a strong genetic and biological basis (Boat et al. 2015). 
Autism spectrum disorders (ASDs) are now defined as group of heterogeneous neurodevelopmental 
conditions such as autism, childhood disintegrative disorder and Asperger syndrome, characterised by 
diminished sociability, impaired communication, restricted interests and stereotypic behaviours (Chen 
et al. 2015; World Health Organization, Geneva 2013). The symptoms include a variable mixture of 
impaired capacity for reciprocal socio-communicative interaction and a restricted stereotyped 
repetitive repertoire of interests and activities (World Health Organization, Geneva 2013). 
Neurodevelopmental impairments in communication, social interaction and unusual ways of 
perceiving and processing information can seriously hinder daily functioning of people with ASDs and 
severely impede their educational and social attainments. Together with the increasing prevalence of 
ASDs diagnosis this has made it an urgent health issue to be studied (World Health Organization, 
Geneva 2013). 
 
1.1.2. Prevalence and genetics of autism 
Epidemiological studies conducted over the past fifty years have shown that the global prevalence of 
ASDs diagnosis has increased, particularly over the last two decades. It is estimated that around 10 
persons in 1000 is now affected worldwide (Elsabbagh et al. 2012). There are many possible 
explanations for this apparent increase in prevalence, namely improved awareness, expansion of 
diagnostic criteria, better diagnostic tools or improved reporting (World Health Organization, Geneva 
2013). 
In Portugal, the reported frequency is lower, around 1 child in 1000 at school age (although the data 
are less recent). The Portuguese isles Açores show an increased rate of 1,56 children in 1000 at school 
age in comparison with the continental rate of 0,92 children in 1000 at school age (Table 1.1) (Oliveira 
et al. 2007). 
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Table 1.1. Prevalence of autism in Portugal. Number of children in Portugal 
surveyed by teachers, selected for assessment, observed and diagnosed with 
ASDs, and prevalence estimates per 1000 children for school-year 1999 to 2000 
by geographic region. 163 cases of children were not represented for unknown 
reasons. None of these children were referred with four or more positive items in 
questionnaire. The values shown have a confidence interval of 95%. This table 
was adapted from (Oliveira et al. 2007). 
Geographic region Prevalence of ASD per 1000 children 
Norte 0,60 (0,50 – 0,75) 
Centro 1,25 (0,96 – 1,50) 
Lisboa e Vale do Tejo 1,23 (1,00 – 1,40) 
Alentejo 0,70 (0,30 – 1,10) 
Algarve 0,24 (0,30 – 0,50) 
Mainland total 0,92 (0,81 – 1,00) 
Azores 1,56 (0,80 – 2,30) 
 
The earliest prevalence studies also found a consistent sex difference, with boys being 3 to 4 times 
more likely to have autism than girls (Boat et al. 2015) (DiLuca et al. 2014) (World Health 
Organization, Geneva 2013). 
It is known that there is a strong genetic component to ASDs, but the situation is usually complex with 
multiple genes contributing to the prevalence of the disorder (Geschwind et al. 2015). However, in a 
minority of cases disruptions of a single gene can result in ASDs, for example mutations in the NF1 
gene cause ASDs as well as other neurodevelopmental problems (Vogel et al. 2017). These 
monogenic disorders provide an entry point into the underlying molecular and biological mechanisms. 
 
1.2. Functional neuroanatomy of the basal ganglia 
The basal ganglia are a group of structures found deep within the cerebral hemispheres and the 
brainstem that include the caudate nucleus, putamen, globus pallidus, subthalamic nucleus and 
substantia nigra. The caudate and putamen form the striatum, and the globus pallidus and substantia 
nigra are each made up of multiple nuclei. The main function of the basal ganglia is processing 
movement related information (intensity, direction and sequence). The other functions are associated 
with emotion, motivation and cognitive functions (Kalat 2012). 
 
 
Figure 1.1. Neuroanatomy of the basal ganglia (Kalat 2012). 
 
The cerebral cortex, responsible for memory, attention, consciousness, language or even perception, 
receives information and sends this stimulus to the caudate nucleus or putamen (main input nuclei of 
the basal ganglia). The globus pallidus and substantia nigra constitute the main output nuclei and send 
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projections out, usually by the thalamus, to the cortex and the brainstem (Matthews 2001; Kalat 2012). 
The basal ganglia pathways have been studied in the last decades and the classical view is that there 
are different circuits in the basal ganglia that promote and inhibit movement. In general, when a signal 
or stimulus to initiate movement is sent from the cortex to the basal ganglia it follows a circuit in the 
basal ganglia known as the direct pathway, which leads to the silencing of neurons in the globus 
pallidus. This allows movement to initiate, once the thalamus is inhibited by the globus pallidus. The 
indirect pathway of the basal ganglia involves the subthalamic nucleus and leads to increased 
suppression of unwanted movements (Squire et al. 2013; Purves et al. 2012). However, it should be 
noted that recent studies have shown that both pathways are co-active during movement suggesting 
that concerted activity the two is required for proper action performance (Klaus et al. 2017; 
Tecuapetla et al. 2014). 
 
1.2.1. Striatal function, morphology and organisation 
The striatum is a small group of structures found below the cerebral cortex that consists of the caudate 
(dorsomedial striatum in rodents), putamen (dorsolateral striatum in rodents), and ventral striatum 
(consists of nucleus accumbens and olfactory tubercle). This major component of the basal ganglia is 
crucial for reinforcement processing after an action and the different sub-regions have dissociable 
functions. The caudate is associated with action-outcome learning whereas the putamen is involved in 
stimulus response learning, and the ventral striatum in mediating motivational and affective learning 
(Figure 1.2) (Klaus et al. 2017; Tecuapetla et al. 2014). 
 
 
Figure 1.2. Nissl staining of a sagittal section of a C57BL/6J mouse brain. The Nissl staining is a classic nucleic acid staining 
method used on nervous tissue sections, where a basic dye (aniline, thionine, or cresyl violet) binds to negatively charged 
nucleic acids like RNA and DNA. B (magnification of 5 x) represents the region delimited by the rectangle in A 
(magnification of 1,25 times (x)), specifically the dorsal striatum region. 
 
The dopamine D1 receptor-expressing striatal medium spiny projection neurons (MSNs) (Figure 1.3) 
that constitute the striatonigral or direct pathway (dMSNs) and the dopamine D2 receptor-expressing 
MSNs that constitute the striatopallidal or indirect pathway (iMSNs) can cooperate and are the two 
subpopulations of MSNs, which constitute mainly the striatum together with a smaller number of 
distinct classes of interneurons (Vicente et al. 2016; Marzluff et al. 2012; Matthews 2001; Squire et al. 
2013). 
 
A B 
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Figure 1.3. MSNs represent 95% of the total number of striatal neurons. The phenotype is characterised by medium size 
(around 20 millimetres (mm) in diameter) with multipolar stellate cells with radially oriented dendrites, which are covered by 
dendritic spines, small postsynaptic specializations (Lanciego et al. 2012). 
 
1.3. The forkhead box family 
The Forkhead box (FOX) proteins are an evolutionarily ancient family of transcription factors 
characterised by a highly conserved forkhead DNA-binding domain with 110 amino acids (Golson et 
al. 2016). The FOXP subfamily proteins (FOXP1-4)1  are unique in that they must homo- or 
heterodimerise to perform their transcriptional function, a process which is mediated through the 
conserved zinc-finger and leucine-zipper domains (Figures 1.4 and 1.5) (Golson et al. 2016). They 
have a wide range of important biological functions in many developmental and differentiation 
processes: FOXP1, FOXP2 and FOXP4 are involved in the lung, heart, gut and central nervous 
system; FOXP3 is linked with the regulatory T cells (Tregs) of the adaptive immune system (Golson 
et al. 2016). The functional importance of this subfamily has been recognised because mutations in 
these genes cause different diseases. For example, mutations in the dimerization domain of FOXP3 
result in IPEX syndrome (immune dysregulation, polyendocrinpathy, enteropathy, X-linked 
syndrome) (Golson et al. 2016). 
 
 
Figure 1.4. Evolution of tree mouse of Fox proteins. The rectangle represents the members of Foxp subfamily: Foxp1-4 
(Hannenhalli et al. 2009). 																																																								1 The standard nomenclature is FOXP for humans, Foxp for mice and FoxP for other species, or when referring to several 
species; genes and RNA are italicised. 
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The FOXP1 and FOXP2 genes have generated interest because of their links with neurodevelopmental 
disorders (Bacon et al. 2012). Disruptions of the FOXP2 gene cause a severe speech and language 
disorder, which has been characterised in detail in the KE family (Vargha-Khadem et al. 2005; 
Morgan et al. 2016). Affected family members carry a missense mutation in the DNA-binding domain 
of FOXP2 which is responsible for wide-ranging impairments in oral and written language which 
impact on both receptive and expressive skills (Figure 1.5) (Watkins et al. 2002; Lai et al. 2001). A 
core phenotype of the disorder is developmental verbal dyspraxia (also known as childhood apraxia of 
speech), where imprecise and inconsistent neural control of sequences of orofacial movements 
impedes development of fluent speech (Watkins et al. 2002). 
 
 
Figure 1.5. Examples of different FOXP1 and FOXP2 mutations described (Bacon et al. 2012). 
 
More recently, it has been shown that disruptions of the FOXP1 gene result in a broader 
neurodevelopmental disorder, including ASDs, speech and language impairment and intellectual 
disability as well as other phenotypes including sensory integration disorder and hypertelorism (Figure 
1.5) (Sollis et al. 2016, 2017; Myers et al. 2017; Bacon et al. 2012). The similarities and differences 
between FOXP1- and FOXP2-related disorders are shown in (Figure 1.6). 
 
 
Figure 1.6. The similarities and differences between phenotypes associated with FOXP1 and FOXP2 disruptions (Bacon et 
al. 2012). 
 
1.3.1. The role of Foxp1 in the developing brain 
Studies in mice have been used to investigate functions of the Foxp2 protein and have uncovered roles 
in motor-skill learning and striatal synaptic plasticity (Groszer et al. 2008; French et al. 2012). 
However, much less is currently known about Foxp1 functions. 
Foxp1 is crucial for embryonic development and regulates cardiac outflow tract, endocardial cushion 
morphogenesis and myocite proliferation and maturation (Wang et al. 2004). 
In the brain, Foxp1 expression has been detected from embryonic day (E) 12,5 in the developing 
telencephalon and expression persists into adulthood. The gene is expressed in the striatum, cortex 
(layers 3 to 5), hippocampus and thalamus (Ferland et al. 2003). In the adult striatum, Foxp1 
expression is found in MSNs with no expression detected in striatal interneurons (Ferland et al. 2003; 
Tamura et al. 2003, 2004). Expression levels are similar in D1- and D2-receptor expressing MSNs 
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(Vernes et al. 2011). It has been shown that FOXP1 is also expressed in the developing human 
striatum over an equivalent gestational period and with a similar anatomical distribution to that seen in 
rodents (Teramitsu et al. 2004). Interestingly, the striatum is a brain region where Foxp1 expression 
overlaps with Foxp2 expression (Ferland et al. 2003), meaning that the proteins could potentially 
heterodimerise and function cooperatively. This was recently shown to occur in vivo in the songbird 
striatal nucleus, Area X (Mendoza et al. 2017). 
Mice with global homozygous deletion of Foxp1 are embryonically lethal (Wang et al. 2004). 
Heterozygous mice are viable and show increased excitability of striatal MSNs and deficits in 
vocalisations (Araujo et al. 2015). Mice with brain-specific deletion of Foxp1 have also been 
generated and have anatomical changes in the striatum as well as electrophysiological abnormalities in 
the hippocampus. These animals also display additional cognitive and social deficits including altered 
vocalisations (Fröhlich et al. 2017; Bacon et al. 2015). 
 
1.4. Project aims 
The project “Investigating striatal functions of Foxp1 in motor-sequence learning, automatisation of 
behaviour and social interaction” involves three main goals: quantify Foxp1 protein knockdown in 
mice with striatum-specific knockdown of Foxp1 and littermate controls and confirm if it is striatum-
specific; study of motor-sequence learning and automatisation of motor behaviour in striatum-specific 
Foxp1 knockdown mice and controls; and assess social approach behaviour and preference for social 
novelty in striatum-specific Foxp1 knockdown mice and controls. 
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2. Materials and Methods 
 
2.1. Animals 
All animal procedures were reviewed and performed in accordance with the Champalimaud Centre for 
the Unknown Ethics Committee guidelines and approved by the Portuguese Veterinary General Board 
(Direção Geral de Alimentação e Veterinária, approval 0421/000/000/2014). 
Animals were maintained and bred in specific pathogen-free barrier facilities at the vivarium of 
Champalimaud Foundation, under a 12 hours (h) light/dark cycle, with controlled temperature and 
humidity (respectively 18 - 24 degrees Celsius (ºC) and 40 - 75 %). Food and water were supplied ad 
libitum, except during the operant motor-sequence learning task (see below). 
Body weight was monitored during development. Male and female animals were tested at the age of 
10 weeks (2 months) to 22 weeks (5 months). Mice were maintained on a mixed genetic background 
(majority C57BL/6J with some CD-1 and 129/Sv), which did not change during the course of the 
study because all experimental animals were the offspring from the same set of breeding pairs. 
 
2.2. Generation of mutant mice 
The conditional gene knockout is a technique used to eliminate a specific gene in a tissue or region in 
alternative to the traditional gene knockout technique, in which a gene mutation can cause embryonic 
death. This new conditional approach also allows the study of a gene at a specific developmental stage 
or in adults (Guan et al. 2010; Zhang et al. 2012; Skarnes et al. 2013). 
Mice with a Foxp1 conditional allele were previously generated using the targeting vector shown 
below (Figure 2.1) (Feng et al. 2010). LoxP sites flank exons encoding the key DNA-binding domain 
of Foxp1. Thus expression of Cre recombinase deletes Foxp1 exons 11 and 12 (Figure 2.1). 
 
 
Figure 2.1. Diagram of the targeting vector containing Foxp1 exons 11 to 14. The Foxp1 conditional construct was designed 
to have short (1,0 kilobase (kb)) and long (6,9 kb) arms of homology. Cre recombinase conditionally deletes Foxp1 exons 11 
and 12 flanked by 2 loxP sites. Flp recombinase deletes the neo marker from the mouse germline (Feng et al. 2010). 
 
To generate mice with Foxp1 disrupted specifically in the striatum, mice with the Foxp1 conditional 
allele (Foxp1flox/flox mice) (Feng et al. 2010) were crossed with mice expressing Cre recombinase under 
control of the Rgs9 promoter, specific for striatal medium spiny neurons (Rgs9-Cre+ mice) (Dang et 
al. 2006) (Figure 2.2). 
 
 
Figure 2.2. Targeting construct for the Rgs9-cre mouse. The striatum-specific Cre mouse was made by employing the 
restricted expression pattern of RGS9 protein, the product of a splice variant of the Rgs9 gene that is expressed 
predominantly in the striatum. A cre gene was inserted at the 3’ end of the Rgs9 gene (Dang et al. 2006). 
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After the mice generation (Figure 2.3) the genotypes were determined by polymerase chain reaction 
(PCR) amplification in order to select the heterozygous mice for Foxp1 conditional allele with the 
disruption of the gene mediated by Cre recombinase (Foxp1flox/+; Rgs9-Cre+) (abbreviated to Foxp1 
heterozygous). 
 
 
Figure 2.3. Generation of Foxp1 heterozygous mice. Foxp1 flox/flox mice were crossed with Rgs9-Cre+ mice. From this 
breeding Foxp1 heterozygous mice were selected for the next breeding step. 
 
Foxp1 heterozygous mice were crossed with Foxp1 flox/flox mice for the generation of mice without 
the Cre-mediated disruption of the gene (Foxp1flox/flox; Rgs9-Cre- and Foxp1flox/+; Rgs9-Cre-) 
(abbreviated to Controls), and mice heterozygous and homozygous for the Foxp1 conditional allele 
with the disruption of the gene mediated by Cre recombinase (Foxp1floxflox; Rgs9-Cre+, abbreviated to 
Foxp1 homozygous) (Figure 2.4). 
 
    
Figure 2.4. Generation of experimental animals with Foxp1 disrupted specifically in the striatum. Foxp1 heterozygous mice 
were crossed with Foxp1flox/flox, resulting in Controls (black), Foxp1 heterozygous (light blue) and Foxp1 homozygous (red) 
mice. 
 
To study the interaction between Foxp1 and Foxp2 genes in the striatum and their possible mutual 
regulation, mice with global heterozygous disruption of Foxp1 and Foxp2 were intercrossed  (Figure 
2.5). The Foxp2 line carries a premature stop codon close to the human R328X nonsense mutation 
found in a second family segregating Foxp2-related speech and language deficits (Foxp2-S321X) 
(Groszer et al. 2008). Foxp1 global heterozygous mice were obtained from the offspring of the 
Foxp1flox/+; Rgs9-Cre x Foxp1flox/flox intercross (Figure 2.4). In rare cases germ line deletion occurred in 
these animals i.e. they genotyped positive for deletion of the loxP flanked sequence but not for Cre 
(Foxp1-∆11-12). The offspring resulting from this cross are as follows: mice with wild-type Foxp1 
and Foxp2 alleles (abbreviated to Controls), mice heterozygous for Foxp1-∆11-12 with wild-type 
(WT) Foxp2 alleles (abbreviated to Het1), mice heterozygous for Foxp2-S321X and with wild-type 
Foxp1 alleles (abbreviated to Het2) and mice heterozygous for Foxp1-∆11-12 and Foxp2-S321X 
(abbreviated to dHet). 
 
Foxp1flox/+; Rgs9-Cre+ or Foxp1flox/+; Rgs9-Cre- 
 
 
 
Foxp1flox/flox Rgs9-Cre+ 
Foxp1flox/flox; Rgs9-Cre- (Controls) 
Foxp1flox/+; Rgs9-Cre- (Controls) 
Foxp1flox/+; Rgs9-Cre+ (Foxp1 heterozygous) 
Foxp1flox/flox; Rgs9-Cre+ (Foxp1 homozygous) 
 
 
Foxp1flox/+; Rgs9-Cre+ Foxp1flox/flox 
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Figure 2.5. Generation of experimental animals to study the interaction between Foxp1 and Foxp2 genes in the striatum. 
Heterozygous mice from Foxp1-Δ11-12 line were crossed with heterozygous mice from Foxp2-S321X line, resulting in 
Controls (black), Het1 (green), Het2 (dark blue) and dHet (orange) mice. 
 
2.3. Genotyping 
2.3.1. DNA extraction 
DNA for use in genotyping was extracted from ear punches or tail biopsies, when the first is not 
possible. Following the DNA extraction kit instructions (REDExtract-N-Amp™ Tissue PCR Kit, 
SIGMA-ALDRICH), 100 microliters (µL) of the extraction solution and 25 µL of the tissue preparation 
solution were added to each sample and incubated at room temperature (RT) for 10 minutes (min), 
followed by a 3 min incubation at 95 ºC (Thermomixer compact, number 5350, Eppendorf). The final 
step was the addition of 100 µL of the neutralization solution B, followed by homogenization in a 
vortex (VWR International). The samples were stored at 4 ºC until the genotyping was completed. 
 
2.3.2. PCR amplification 
Mice were genotyped using PCR amplification to determine whether the Foxp1 conditional allele was 
present and to determine the presence of the Cre gene. To evaluate the interaction between Foxp1 and 
Foxp2 genes, PCR amplification was also performed to genotype mice from Foxp1-Δ11-12 and 
Foxp2-S321X lines. 
The PCR reagents were added in accordance to the PCR kit instructions (REDExtract-N-Amp™ Tissue 
PCR Reaction Mix, SIGMA-ALDRICH) (Table 2.1). 
 
Table 2.1. Quantities of PCR reagents added in each reaction tube. x 
represents the volume of water added to make up to 20 µL of total 
volume. y represents the volume of each primer (forward and reverse) 
added to maintain a concentration of 0,4 micromolar (µM) in the 
reaction. Adapted to REDExtract-N-Amp™ Tissue PCR Kit Protocol 
(SIGMA-ALDRICH). 
Reagent Volume (µL) 
Water x 
REDExtract-N-Amp PCR Reaction Mix 10 
Forward Primer 0,5 µM y 
Reverse Primer 0,5 µM y 
Tissue Extract 4 
Total volume 20 
 
Specific primer combinations were used for each PCR reaction. The Foxp1 PCR reaction was used to 
investigate the presence/absence of Foxp1 conditional allele. Cre1 and Cre2 PCR reactions were 
performed to conclude about the presence/absence of the Cre recombinase gene. Foxp1-∆11-12 
Foxp1+/+; Foxp2+/+ (Controls) 
Foxp1Δ11-12/+; Foxp2+/+ (Het1) 
Foxp1+/+; Foxp2S321X /+ (Het2) 
Foxp1Δ11-12/+; Foxp2S321X/+ (dHet) 
 
 
Foxp1Δ11-12/+ Foxp2S321X/+ 
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reaction was used to detect the deletion of the neo marker from the mouse germline in order to 
generate mice with a germline Foxp1 mutation. Foxp2-S321X reaction was performed to evaluate the 
presence of the mutation resulting in the premature Foxp2 stop codon (Table 2.2). 
 
Table 2.2. Specific primer combinations used for mice genotyping. Foxp1cKO1 and Foxp1cKO2 were used 
for the Foxp1 PCR reaction. Cre-F, Cre-R, MT3-F and MT3-R were used for the Cre1 PCR reaction. Cre-3 
and Cre-4 were used for the Cre2 PCR reaction. CK01 and 10R were used for the Foxp1-∆11-12 PCR 
reaction. 7F and 7R were used to perform the Foxp2-S321X PCR reaction. All primers were purchased from 
SIGMA-ALDRICH. 
PCR reaction Primers Nucleotide sequence 
Foxp1 
Foxp1cKO1 5’- CTC CTA GTC ACC TTC CCC AGT GC -3’ 
Foxp1cKO2 5’- GAA CAC TGT CGA ATG ACC CTG C-3’ 
Cre1 
Cre-F 5’- GGT TTC CCG CAG AAC CTG AA -3’ 
Cre-R 5’- AGC CTG TTT TGC ACG TTC ACC -3’ 
MT3-F 5’- CCT AGC ACC CAC CCA AAG AGC TG -3’ 
MT3-R 5’- GGT CCT CAC TGG CAG CAG CTG CA -3’ 
Cre2 
Cre-3 5’- CAC TCA TGG AAA ATA GCG ATC-3’ 
Cre-4 5’- ATC TCC GGT ATT GAA ACT CCA GCG C -3’ 
Foxp1-∆11-12 
CK01 5’ - CTC CTA GTC ACC TTC CCC AGT GC - 3’ 
10R 5’ - CAC CCT CTC CAA GTC TGC CTC AG - 3’ 
Foxp2-S321X 
7F 5’ – ATA GTA TGG AAG ACA ACG GCA TC - 3’ 
7R 5’ – GAT GGG GTT AGT GAA TGT TCT CA - 3’ 
 
The PCR reaction tubes were gently mixed. The final step was the PCR amplification reaction in a 
thermocycler (C-1000 Touch Thermal Cycler, CFX96 Real-Time System, Bio-Rad), using the 
optimised amplification parameters shown bellow (Tables 2.3 to 2.5). 
 
Table 2.3. Optimised amplification parameters of PCR reaction Foxp1. T 
represents the temperature of the PCR step in ºC. s represents the time in 
seconds. 
PCR step 
PCR reaction 
Foxp1 
T (ºC) Time Cycles 
Initial denaturation 95 15 min 1 
Denaturation 
Annealing 
 
Extension 
Denaturation 
Annealing 
Extension 
95 30 s 
13 
65 to 58 
(touchdown 0,5/cycle) 
30 s 
72 45 s 
95 30 s 
25 58 30 s 
72 40 s 
Final extension 72 7 min 1 
Holding 4 - - 
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Table 2.4. Optimised amplification parameters of PCR reactions Cre1 and Cre2. T represents the 
temperature of the PCR step in ºC. 
PCR step 
PCR reactions 
Cre1 Cre2 
T (ºC) Time Cycles T (ºC) Time Cycles 
Initial denaturation 94 3 min 1 94 2 min 1 
Denaturation 
Annealing 
Extension 
94 30 s 
35 
94 45 s 
35 58 30 s 60 1 min 
72 30 s 72 90 s 
Final extension 72 5 min 1 72 8 min 1 
Holding 4 - - 4 - - 
 
Table 2.5. Optimised amplification parameters of PCR 
reactions Foxp1-∆11-12 and Foxp2-S321X. T represents the 
temperature of the PCR step in ºC. 
PCR step 
PCR reactions 
Foxp1-∆11-12 
Foxp2-S321X 
T (ºC) Time Cycles 
Initial denaturation 95 15 min 1 
Denaturation 
Annealing 
Extension 
94 1 min 
35 55 1 min 
72 1 min 
Final extension 72 10 min 1 
Holding 4 - - 
 
2.3.2.1. Restriction enzyme digest 
The mutation in the Foxp2-S321X line results in the formation of an AflII restriction enzyme site, 
which is utilised for genotyping (Figure 2.6). A restriction enzyme digestion with AflII (cat. R0520S, 
New England BioLabs) was performed as shown in Table 2.6. 
 
 
Figure 2.6. Sequence traces showing each heterozygous mutation with corresponding changes in coding sequence (Groszer 
et al. 2008). 
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Table 2.6. Quantities of restriction enzyme 
digest. Quantities of reagents added in each 
reaction tube (cat. R0520S, New England 
BioLabs). 
Reagent Volume (µL) 
Water 6,45 
AflII 0,25 
BSA 0,3 
10X CutSmart buffer 3 
PCR product 20 
Total volume 30 
 
The restriction enzyme digestion tubes were gently mixed. The final step was the incubation in a 
thermocycler (C-1000 Touch Thermal Cycler, CFX96 Real-Time System, Bio-Rad) for 3 h at 37 ºC. 
 
2.3.3. Gel electrophoresis 
Agarose gels were used to separate DNA fragments of different sizes in PCR samples. Gels with 
specific concentrations of agarose (ThermoFisher Scientific) for each PCR protocol (Tables 2.3 and 
2.4) were made in 1% Tris-acetate-EDTA (TAE) (Sigma-Aldrich) running buffer. 3,5 µL/50 millilitres 
(mL) of loading dye (DNA Gel Loading Dye, ThermoFisher Scientific) was added to facilitate the 
visualisation of the gel bands. A 100 base pairs (bp) ladder (Precision molecular mass standard, Bio-
Rad) was used to determine the size of the bands. The gel was run at ≈ 140 Volts (V) for 50 min and 
viewed under ultraviolet light (UV) in a transilluminator (ChemiDoc™ MP System, Bio-Rad). The 
genotype of the animals could then be determined, according to the expected size of the bands (Table 
2.6). 
 
Table 2.7. Expected sizes of the genomic fragments. 
Expected sizes, in bp, of the genomic fragments for 
each region, which allows the mice genotyping (Feng et 
al. 2010; Dang et al. 2006; Groszer et al. 2008). 
PCR reaction Fragment Size (bp) 
Foxp1 
WT 280 
Conditional 370 
Cre1 
WT 300 
Cre 150 
Cre2 Cre 500 
Foxp1-∆11-12 
WT 1200 
Mutant 450 
Foxp2-S321X 
WT 468 
Mutant 135 and 332 
 
2.4. Perfusion and dissection 
For histology, all of the blood from the brain was removed, since it would interfere with the staining 
and the correct visualization of the brain cells. The perfusion and dissection were performed as 
previously described (Gage et al. 2013). 
Beforehand, the apparatus and solutions for the perfusion, a peristaltic pump (Flex-Pro A2 Peristaltic 
Metering Pump, Blue-White), phosphate-buffered saline (PBS) (Glasswash and Media Preparation 
Platform, Champalimaud Foundation) and fixative paraformaldehyde 4 % (PFA) (Glasswash and 
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Media Preparation Platform, Champalimaud Foundation) were prepared and assembled as shown 
bellow (Figure 2.5). 
Mice were weighed and lightly anesthetized with cotton soaked with isoflurane (JD Medical) and then 
deeply anesthetized with an intraperitoneal injection of ketamine/xylazine mixture: 12 % body weight 
ketamine (Imagene) and 8 % body weight xylazine (Rompun xylazine 100 milligrams (mg)/mL 
Injectable, Bayer DVM) (0,01 mL per g of body weight). The perfusion technique consisted of 
opening the abdomen, cutting through the peritoneum and carefully separating the liver from the 
diaphragm. To reach the heart, the diaphragm was cut to expose the pleural cavity and the sternum 
clamped and placed over the head. Then the perfusion needle connected with the peristaltic pump was 
inserted on the left ventricle into the ascending aorta and a small incision was made on the right atrium 
(Figure 2.4). 
 
 
Figure 2.7. The major steps of mice perfusion. 
 
This allowed the PBS to replace the blood all over the animals’ body, and the blood to exit through the 
right atrium. After approximately 15 to 20 min, all the blood was replaced by the buffer (PBS) and 
then by the fixative (PFA). 
 
 
Figure 2.8. Schematic diagram showing the perfusion steps. 
 
After the perfusion step, the brain was carefully removed from the head. A midline incision from the 
neck to the nose was made and the skull was exposed. Carefully, the skull was removed and the brain 
was exposed (Figure 2.6). 
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Figure 2.9. The major steps of brain dissection. 
 
The brain was stored in PFA for at least 24 h before being sectioned and then embed in PBS. 
 
2.5. Brain sectioning 
After incubation in PFA, the brain was sectioned using a vibratome (VT 1000 S, Leica). The apparatus 
was prepared in accordance with machine instructions. The brain was embedding in agarose 2,4 % to 
facilitate the sectioning. Sections were floated off the specimen in PBS and placed in multiwell plates 
and then stored at 4 ºC until histological procedures. 
 
2.6. Immunohistochemistry 
Sections were washed for 3 x 5 min in phosphate-buffered saline (PBS) (Glasswash and Media 
Preparation Platform, Champalimaud Foundation) and placed in 3 % hydrogen peroxide (H2O2) 
(Glasswash and Media Preparation Platform, Champalimaud Foundation) for 10 min to quench 
endogenous peroxidases. Following 3 x 5 min washes in PBS sections were put in blocking solution 
(5% heat inactivated horse serum (New Zealand Origin, catalog number 26050070, Gibco), 2 % 
Bovine Serum Albumin (Lot #SLBL2871V, Sigma-Aldrich) and 0,2 % Triton-X 100 (Lot 
#110M00093V, Sigma)) for 45 min. Subsequently the sections were incubated overnight (ON) at room 
temperature (RT) in primary antibody, rabbit monoclonal antibody to FOXP1 (ab134055, [EPR4113], 
Lot GR97096-11, abcam) 1:200 in blocking solution. The following day, sections were washed 3 x 5 
min in PBS before incubating in secondary antibody, biotin-conjugated donkey anti-rabbit IgG (Lot 
86689, Jackson ImmunoResearch) 1:500 for 2 h at RT. Then sections were washed 3 x 5 min in PBS 
before incubating in Vectastain ABC KIT Standard (Elite ABC, Vector Laboratories) for 30 min at 
RT. The sections were washed 3 x 5 min in PBS before the incubation in peroxidase substrate 
ImmPACT DAB (3,3-diaminobenzidine substrate) (Vector Laboratories) for 7 min, after which the 
reaction was immediately stopped with tap water. Sections were mounted onto slides (Superfrost Plus, 
Thermo Scientific) and left to dry ON. They were then washed in tap water for 2 min and dehydrated 
through a molecular grade ethanol (Lot 1201930, Fisher Chemical) series for 2 min at each 
concentration (50 %, 70 %, 90 %, 100 % and 100 %). Then the sections were washed in histological 
clearing agent Histo-Clear (Lot 04-12-31, national diagnostics) and mounted with histological 
mounting medium Histomount (Lot 03-08-20, national diagnostics) with coverslips (Thermo 
Scientific). 
The brain sectionss were imaged on a Widefield Fluorescence Scanning Microscope (Axio Imager M2, 
Zeiss) and analysed with AxioVision Microscopy Software (Version 4.8.2, Zeiss) with Image 
Processing and Analysis in JAVA (ImageJ). 
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2.7. Western blot 
2.7.1. Protein extraction 
Tissues from the striatal and cortex regions of Foxp1 homozygous and Control mice was dissected 
into lysis RIPA buffer (Lot #SLBL7395V, Sigma-Aldrich), 0,5 mL for 50 mg of sample, after the 
addition of phosphatase inhibitor (PhosSTOP EASYpack, reference 04906837001, Roche) and 
protease inhibitor (cOmplete Tablet, Mini EDTA-free EASYpack, reference 04693159001, Roche), in a 
proportion of 1 tablet of each for 10 mL of RIPA buffer. Then, the tissues were disrupted by 
homogenisation (Potter-Elvehjem, RW16 basic, IKA) and subsequently by sonication (Vibra Cell 
sonicator, model 75185, Bioblock Scientific) at 30 % of amplitude for approximately 30 s. Lysates 
were centrifuged at 10000 relative centrifugal force (G) for 10 min. 
 
2.7.2. Protein quantification 
The protein concentrations of the supernatants were determined by Pierce BCA Protein Assay (Lot 
#NE173647, Thermo Scientific) in accordance with kit instructions. The working reagent was prepared 
by the addition of reagent A to reagent B in a proportion of 50:1. Standards and samples were added to 
microplates in triplicate, with a protein sample to working reagent ratio of 1:8. The samples were 
incubated at 37 ºC for 30 min and then moved to RT for 5 min. The quantification was performed in 
the spectrophotometer NanoDrop (model 2000/2000c, Thermo Scientific). The values obtained were 
used to determine the standard curve and then the protein concentration of each sample. 
 
2.7.3. Gel electrophoresis 
The loading buffer for gel electrophoresis was prepared with Laemmli sample buffer (cat. #1610737, 
Bio-Rad) and 2-Mercaptoethanol (cat. #1610710, Bio-Rad) with a ratio of 10:1. A sample volume 
equivalent to 30 µg of protein was added to the loading buffer. Samples were then heated at 100 ºC for 
10 min and centrifuged for 30 s. The protein samples were ran on commercial gels (Mini-PROTEAN® 
TGX™ Precast Gels, 4-15 %, Bio-Rad). To preparing the cassette, the comb was removed by pulling 
upward and the tape was also removed from the bottom of the cassette, according to the Mini-
PROTEAN® TGX™ Precast Gel Quick Start Guide (Rev C, document number 10026447, Bio-Rad). 
To assemble the Mini-PROTEAN Tetra Cell (Bio-Rad), the running buffer was added to the inner and 
outer chambers and the wells were cleaned. The samples and the Precision Plus Protein™ WesternC™ 
standards (Bio-Rad) were load into the wells in a total volume of 15 µL per well. 
 
2.7.4. Semi-dry transfer 
To perform the electrophoretic protein transfer, a semi-dry transfer method was used. The transfer 
buffer (500 mL per transfer) was prepared with 100 mL of methanol, 100 mL of transfer buffer 5x 
(60,6 gramme (g) Trizma base (Sigma-Aldrich), 288 g Glycine (Calbiochem) and deionized water up 
to 4 L) and 300 mL of deionized water. The membrane was soaked in methanol for 5 min and then 
into the transfer buffer previously prepared. The “sandwich” assembly was constructed according to 
the kit instructions (Figure 2.7). The transfer occurred at 12 V for 1 h. To check if the proteins had 
correctly transferred from the gel to the membrane, the latter was soaked in 5 mL of Ponceau stain. To 
remove the staining the membrane was washed 3 x 5 min in a mixture of tris-buffered saline (TBS) 
and Polysorbate 20 (Tween 20) (TBST). 
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Figure 2.10. Assembly of the Trans-Blot SD semi-dry cell. 
 
2.7.5. Antibody probing 
The blocking solution was prepared with 5% of Blot-Grade Blocker in a mixture of TBST. The 
membranes were incubated in blocking solution for 1 h at RT. The primary antibody incubation was 
done with primary antibody rabbit monoclonal antibody to FOXP1 (ab134055, [EPR4113], lot no. 
GR97096-11, abcam) 1:200 in blocking solution and primary antibody monoclonal anti-β-actin 
(produced in mouse, monoclonal AC-15, product number A5441, lot no. 121M4846, Sigma-Aldrich) 
1:100000 in blocking solution. The membrane was washed 3 x 15 min in TBST before the secondary 
incubation for 1 h at RT in the respective secondary antibody: donkey anti-rabbit conjugated 
horseradish peroxidase (HRP) for Foxp1 1:2000 in blocking solution and goat anti-mouse conjugated 
HRP for β-actin 1:2000 in blocking solution. The membrane was washed 3 x 15 min in TBST and then 
was cut between the bands 50 kilodalton (kD) and 75 kD. Foxp1 band is expected have a size of 75 kD 
and β-actin a size of 42 kD. 
 
2.7.6. Detection 
The detection solutions Amersham™ ECL™ Prime Western Blot Detection Reagent (GE Healthcare) 
were left at RT for 20 min to equilibrate before the incubation. The reagents A and B, iluminol and 
peroxide, were mixed in a ratio of 1:1 to a working solution, with a final volume of detection reagent 
of 0,1 mL/centimeter2 (cm2) membrane. The Foxp1 and β-actin membranes were incubated with 
detection reagent during specific periods for each condition (Table 2.7). 
 
Table 2.8. Time of incubation. Time of incubation in 
Amersham™ ECL™ Prime Western Blot Detection Reagent (GE 
Healthcare). 
 Foxp1 membrane β-actin membrane 
Cortex 
5 min 
30 s 
Striatum 10 s 
 
After the incubation with the detection reagent, membranes were rinsed in deionised water and placed 
on a plastic sheet. Following the detection on the imaging apparatus Amersham™ Imager 600 (GE 
Healthcare) with the times described in Table 2.8. 
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Table 2.9. Time of exposure. Time of exposure in the imaging 
apparatus Amersham™ Imager 600 (GE Healthcare). 
 Foxp1 membrane β-actin membrane 
Cortex 72 min 15 s 
Striatum 10 min 1 s 
 
2.7.7. Data analysis 
The protein detection images, namely the density of bands on western blot were analysed with ImageJ, 
in accordance with Luke Miller’s protocol (Miller 2010). 
The images were opened in the software (File > Open) and converted to grayscale (Image > Type > 8-
bit). Rectangular selections (Rectangular Selection from the ImageJ toolbar) were drawn around each 
lane or well. To identify each lane, a number was assigned (Analyse > Gels > Select First Lane or 
Select Next Lane). This step was followed by the creation of a profile plot of each lane (Analyse > 
Gels > Plot Lanes), which represents the relative density of the contents of the rectangle over each 
lane, from top to bottom. As images of real western blots will always have some background, it was 
necessary to close off the peak so that the size could be measured (Straight Line selection from the 
ImageJ toolbar). Subsequently the highlighted peaks (Wand tool from the ImageJ toolbar) and the 
respective sizes (Analyse > Gels > Label Peaks), expressed as a percentage of the total size of all of 
the highlighted peaks, using a peak as a standard. The calculation of the relative density was done by 
dividing the percentage value of each lane by the percentage value of the standard. 
 
2.8. Accelerating rotarod 
The rotarod test was used to provide an overall assessment of motor coordination, balance and 
evaluation of motor-skill learning of adult mice. 
A computer-interfaced rotarod (ENV-577MAX, Med Associates Inc., Georgia, Vermont, United 
States of America) was set to accelerate from 6 to 60 revolutions per minute (rpm) over a 300 s time 
period. Mice (with more than 10 weeks or 2 months of age) were trained for 5 consecutive days with 1 
daily session consisting of 10 trials separated by 300 s resting periods. Mice were placed forward on 
the rotarod and trials were deemed to have started when the rod began to turn. Trials ended when mice 
fell from the rod or after 300 s elapsed. If the mouse immediately fell off at the beginning of the first 
trial, that trial was not considered and the mouse performed a new trial. At the end of each trail, the 
apparatus was sprayed with ethanol 70 % and wiped clean with paper towels. 
Learning rate was calculated as follows: !"#$ !"#$%&' !" !"##!"#$%& ! !"# !"!!"#$ !"#$%&' !" !"##!"#$%& ! !"# !!  (2.1) 
 
 
Figure 2.11. Mice performing the accelerating rotarod task. 
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2.9. Operant motor-sequence learning task 
The operant motor-sequence learning task is used to investigate the learning and performance of novel 
motor-sequences of adult mice (around 13 weeks or 3 months of age). 
Before the first day of training mice were submitted to 48 h of food restriction and 12 h of water 
deprivation, and were then maintained at around 85 % of their original body weight for the duration of 
the task. Mice were habituated in operant chambers housed in sound attenuating boxes (Med-
Associates, St. Albans) as previously described (Jin et al. 2010). 
 
  
Figure 2.12. Operant chambers. A lever was extended to the left of a food magazine containing a metal cup into which 10% 
sucrose solution was delivered from a syringe pump. 
 
For habituation, animals were placed into the chambers for 30 min of exploration. The day after, the 
lever was extended and a reinforcement was delivered after each press. The possible number of 
reinforces earned increased each day (5, 15, 30). A session was completed after the number of 
reinforcements had been delivered or 90 min passed. As soon as mice got the thirty reinforcements in 
90 min, the acquisition period ended and the main part of the task began. Mice get a sucrose 
reinforcement after eight lever presses (fixed-ratio 8 schedule, FR8). Initially pressing is self-paced, 
but after twelve days of training (also called self-paced FR8 period) a time constraint is added and the 
eight presses must be completed at increasingly high speeds (first day - 8 presses in 16 s, second day - 
8 presses in 12 s, subsequent days - 8 presses in 8 s, 6 s, 4 s and 2 s) (also known as high-speed FR8 
period) (Figure 2.10). The task takes approximately 30 consecutive days to complete and allows 
detailed analyses of the microstructure of lever-pressing behaviour. 
Data recorded included the number of lever presses, the syringe pump activations, head entries into the 
food magazine (detected by infrared beam) and the number of licks in the cup (detected by contact 
lickometer). 
 
 
Figure 2.13. Operant motor-sequence learning task timeline. The experience starts with an acquisition period. Follow the 
self-paced FR8 and it ends with a high-speed FR8 period. 
 
2.10. Sociability and social preference for social novelty task 
Sociability and preference for social novelty were tested in adult mice (around 22 weeks or 5 months 
of age) using a rectangular three-chamber box (each chamber 300 x 150 x 150 mm) with a door (50 x 
50 mm) in each delimiting wall, which allows free access to each chamber (Figure 2.11). This task is 
divided into two different phases: the first is to investigate social interaction or the tendency to spend 
time with another conspecific and the second is to visualise the preference for social novelty or the 
ability to discriminate and choose between familiar and new conspecifics (Yang et al. 2011; Moy et 
al. 2007).The test mouse was placed in the centre chamber with doors opened during 10 min for 
habituation and exploration of the compartments and the empty cups. To give a choice between 
spending time in the side containing an unfamiliar or stranger conspecific mouse (C57BL/6J mouse of 
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the same gender as the test mouse without previous physical contact with the test mouse) or remaining 
alone, a stranger mouse was placed in a cup for 5 min, to allow visual, auditory, olfactory and tactile 
stimuli (social interaction). In the second phase of the task, a second unfamiliar or specific stranger 
conspecific mouse was placed in a cup in the other side for 5 min (preference for social novelty). The 
location for the first stranger was alternated between the left and right sides of the social test box 
across subjects. The task was video taped for each mouse. 
 
 
Figure 2.14. Three-chamber apparatus. 
 
2.11. Analyses and statistics 
Graphs and statistical analyses were done with GraphPad Prism software. Data were analysed using 
two-way analysis of variance (ANOVA) or two-way repeated measures ANOVA followed by 
Dunnett’s post hoc tests where appropriate. Lever-press data was analysed using Custom written 
Matlab code (Mathworks, Natick, MA, USA). Videos from the social interaction and preference for 
social novelty test were analysed using the video tracking system ANY-maze (San Diego Instruments, 
San Diego, USA). Close interaction behaviour was also scored manually. 
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3. Results 
 
3.1. Generation of mice with striatal-specific disruption of Foxp1 
Foxp1, a gene linked with ASDs, is expressed in the cortex, hippocampus, thalamus and striatum of 
the mouse brain. To determine the functions of Foxp1 in the striatum, the brain region involved in 
action related to habitual learning and goal-directed learning, a transgenic mouse line was created. 
Foxp1flox/flox mice were crossed with Rgs9-Cre+ mice to generate mice with Foxp1 disrupted 
specifically in the striatum. In order to obtain transgenic mice with Foxp1 specifically deleted in the 
striatum in homozygosity and heterozygosity, Foxp1 heterozygous mice from the previous breeding 
were selected and crossed with Foxp1flox/flox mice (see Materials and Methods 2.2 for details). The PCR 
reaction Foxp1 was used to detect the presence of Foxp1 conditional alleles. To detect the success of 
the disruption of the Foxp1 gene mediated by Cre recombinase, the PCR reactions Cre1 and Cre2 
were performed (Figure 3.1). 
 
 
Figure 3.1. Example PCR analysis of experimental animals using Foxp1, Cre1 and Cre2 reactions. Shown is a PCR result 
indicating the presence of the WT Foxp1 allele (280 bp) in animals 1 and 2, and the conditional Foxp1 allele in animals 1,2 
and 3 (370 bp). The gel also shows the presence of the Cre recombinase gene for animals 2 and 3 (Cre has 150 bp and 500 bp 
for Cre1 and Cre2 PCR reactions respectively). Animals with different genotypes are identified with “1”, “2” or “3”. 
 
For the Foxp1 PCR reaction, the expected sizes of the DNA fragments are 280 bp and 370 bp for WT 
and conditional fragments respectively (Table 2.7). Animal 3 revealed only a dense band with 370 bp 
and animals 1 and 2 showed WT and conditional fragments. The analysis of Foxp1 PCR reaction 
identified animals 1 and 2 as heterozygous and animal 3 as homozygous for Foxp1 conditional allele. 
The Cre1 PCR reaction expected sizes of the DNA fragments are 300 bp and 150 bp for WT and Cre 
fragments respectively (Table 2.7). Animals 2 and 3 had two fragments with approximately 150 bp 
and 300 bp, the presence of smaller fragment (150 bp) indicates the presence of Cre. 
The Cre2 PCR reaction was done to confirm the Cre1 PCR reaction result. The expected size for Cre 
fragment is 500 bp (Table 2.7). The PCR analysis for animal 1 does not show any Cre fragment, as 
opposed to animals 2 and 3, who have a single fragment with 500 bp, indicating the presence of the 
Cre. 
In accordance with the PCR analysis, animal 1 (Foxp1flox/+; Rgs9-Cre-; heterozygous for the Foxp1 
allele; absence of the Cre) is a Control, animal 2 (Foxp1flox/+; Rgs9-Cre+; heterozygous for the Foxp1 
allele; presence of the Cre) is a Foxp1 heterozygous and animal 3 (Foxp1flox/flox; Rgs9-Cre+; 
homozygous for the Foxp1 allele; presence of the Cre) is a Foxp1 homozygous. 
 
3.2. Foxp1 protein expression in mice with striatal-specific Foxp1 disruption 
Extracts from the striatal and cortex regions were analysed by western blot using a monoclonal 
primary antibody to Foxp1 and a primary antibody to β-actin housekeeping protein, to determine the 
impact of Cre-mediated deletion at the protein level. In order to compare the protein expression levels 
between several samples from different genotypes (Controls and Foxp1 homozygous) on the same 
blot, the housekeeping protein β-actin was used to normalise the data (Figure 3.2). 
 
370 bp 
280 bp 
Foxp1 
1 2 3 
300 bp 
150 bp 
Cre1 
1 2 3 500 bp 
Cre2 
1 2 3 
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Figure 3.2. Western blot. Western blot analysis of Foxp1 in cortex and striatum regions of Controls (n=4) and Foxp1 
homozygous (n=4) mice. The expected sizes for Foxp1 and β-actin proteins are 75 kD and 42 kD respectively. 
 
A single band corresponding to full-length Foxp1 was observed in Controls (a number of other bands 
were also visible which in some cases corresponded to predicted Foxp1 isoforms and in other cases 
were non-specific). Unexpectedly, this band was also present in Foxp1 homozygous extracts at similar 
levels to what was observed in Controls. 
The protein bands were analysed with ImageJ, in accordance with Luke Miller’s protocol (Miller 
2010), to compare the relative density of bands quantitatively (Figure 3.3). This analysis supported out 
initial observations but was problematic because of the high levels of background present on the 
Foxp1 blots, caused by the long exposure times needed to visualise bands. The Foxp1 antibody had to 
be used at a high concentrations (1:200) and did not appear to recognise the epitope well under the 
denaturing conditions found in western blot. 
This data suggests that Foxp1 was not deleted in mice with striatal-specific disruption of Foxp1. 
Nevertheless, due to the technical difficulties encountered with the western blot a 
immunohistochemistry was also performed. 
 
 
Figure 3.3. Relative density. Relative density of protein in Foxp1 and β-actin protein bands in cortex and striatum regions of 
Controls (n=4) and Foxp1 homozygous (n=4) mice. n represents the number of subjects in each condition. Data shown are 
represented as mean ± standard error of the mean (SEM). 
 
3.3. Histological validation shows striatal-specific Foxp1 knockdown rather than knockout in 
Foxp1 homozygous mice 
For the histological validation of mice with striatal-specific Foxp1 disruption, immunohistochemistry 
was performed using a monoclonal primary antibody to Foxp1 (Figure 3.4). In immunohistochemistry 
conditions, where proteins retain their native configuration, the Foxp1 antibody worked efficiently and 
specifically. 
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	 	Controls Foxp1 homozygous 
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Figure 3.4. Immunohistochemistry. Representative images of immunohistochemistry of cortex and striatum of Controls (A) 
and Foxp1 homozygous (B) with a magnification of 20 x. 
 
Foxp1 loss was substantial in the dorsal striatum and appreciable in the ventral striatum of Foxp1 
homozygous mice compared to Controls. Similar results were seen in 3 Foxp1 homozygous and 3 
Control brains and sections from each genotype underwent DAB development for equal amounts of 
time. In general, deletion was not complete in the striatum of Foxp1 homozygous mice and this line 
therefore represents a striatal-specific knockdown rather than a striatal-specific knockout. 
 
3.4. Mice with selective Foxp1 disruption in the striatum are viable and show normal 
development 
Considering equal feeding and maternal care, mouse pups body weight was measured at postnatal days 
6, 8, 10, 12, 15, 18 and 21 from Foxp1 homozygous, Foxp1 heterozygous and Controls (Figure 3.5). 
 
 
Figure 3.5. Weight development. Weight development of Controls (n=34), Foxp1 heterozygous (n=7) and Foxp1 
homozygous (n=13) between postnatal days 6 and 21. Data shown are represented as mean ± SEM.  
 
Homozygous and heterozygous conditional knockdown mice appeared normal and increased their 
weight at the same rate as control littermates (effect of genotype F1, 2 = 0.10, p > 0.05) (Figure 3.5). 
These data indicating that Foxp1 knockdown in the striatum does not grossly affect mouse 
development. 
 
3.5. Striatal-specific Foxp1 knockdown mice do not show gross motor impairment 
Experimental mice were tested on the accelerating rotarod to investigate motor-skill learning. Mice 
were trained for 5 consecutive days, with one daily session of 10 trials spaced by 300 s of interval, 
with an acceleration rate of 6 – 60 rpm (Figure 3.6). 
A B 
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Figure 3.6. Latency to fall. Latency to fall of Controls (n=16), Foxp1 heterozygous (n=9) and Foxp1 homozygous (n=10) 
mice during training on the accelerating rotarod. Data shown are represented as mean ± SEM. *p < 0.05. 
 
Learning was evident in all genotypes over the course of training (time x genotype interaction F98, 1568 
= 1.53, p < 0.05). However, Foxp1 homozygous mice showed a reduced latency to fall during the 
latter part of day 1 compared to Controls, which was significantly different on trials 6 and 8. The 
learning rate was also significantly reduced in Foxp1 homozygous mice on day 1 (calculated by 
comparing performance on the first and last days of training, see Materials and Methods) (Figure 3.7). 
This deficit is somewhat unusual in that is very transient and would need to be verified in a second 
cohort of animals. However, careful examination of the data showed that it cannot be attributed to the 
poor performance of one or two animals in the cohort. 
 
 
Figure 3.7. Learning rate. Rate of learning in Controls (n=16), Foxp1 heterozygous (n=9) and Foxp1 homozygous (n=10) 
mice during training on the accelerating rotarod. Data shown are represented as mean ± SEM. *p < 0.05. 
 
3.6. Striatal-specific Foxp1 knockdown mice learn and perform sequences of lever-presses 
normally 
An operant lever-pressing task was used to investigate the learning and performance of novel motor-
sequences in striatal-specific Foxp1 knockdown mice. This task has previously been used to show 
disrupted learning and performance of motor-sequences in mice with striatal-specific deletion of the 
NMDA receptor (Jin et al. 2010). It was also observed increased or decreased variability of lever-
pressing in mice with striatal-specific deletion of Foxp2 or a mouse model of ASDs respectively 
(French, C. and Martins, G. unpublished data). In this task mice get sucrose reinforcement after eight 
lever presses (FR8). Initially pressing is self-paced, but after twelve days of training a time constraint 
is added and the eight presses must be completed at increasingly high speeds (first day – 8 presses in 
16 s, second day – 8 presses in 12 s, subsequent days – 8 presses in 8 s, 6 s, 4 s and 2 s), in accordance 
with the timeline showed in Figure 2.13. There is no signalling of the correct number of presses or the 
availability of the sucrose reinforce. 
The operant lever-pressing task allows observe the number of lever presses and reinforcements and 
calculate their respective rates (Figure 3.8). 
 
 24 
 
Figure 3.8. Operant lever-pressing. Lever press rate (A) and rate of reinforce delivery (B) of Controls (black) (n=11), Foxp1 
heterozygous (light blue) (n=9) and Foxp1 homozygous (red) (n=8) through the task. Data shown are represented as mean ± 
SEM. *p < 0.05.  
 
Rates of lever-pressing and reinforce delivery increased during the self-paced phase of training and 
then decreased in the final days of the high-speed phase when the task became more difficult (LP rate 
- time x genotype interaction F30, 375 = 2.18, p < 0.05; effect of time F15, 374 = 9.97, p < 0.05: RD rate - 
time x genotype interaction F30, 375 = 1.92, p < 0.05; effect of time F15, 374 = 11.07, p < 0.05). However, 
no consistent differences were seen between genotypes (LP rate – effect of genotype F2, 25 = 1.08, p > 
0.05: RD rate – effect of genotype F2, 25 = 1.12, p > 0.05) except in the 8 s and 6 s days when rates 
were reduced in Foxp1 heterozygous and Foxp1 homozygous mice (Figure 3.8 A and B). These data 
suggest that Foxp1 heterozygous and Foxp1 homozygous mice are able to learn and perform lever-
press sequences. 
Concatenation or “chunking” of lever-press sequences has previously been shown to occur in the FR8 
task with training, a process which is disrupted when striatal circuits are perturbed (Jin et al. 2010). 
Consistent with these data, pressing in the self-paced training phase became progressively organised 
into discrete sequences, with the number of presses in a sequence increasing across training in all 
genotypes (Figure 3.9 A) (effect of time F11, 275 = 15.78, p < 0.05). However, no differences were seen 
between genotypes in sequence length, sequence duration, inter-sequence interval or within sequence 
press rate (Figure 9 B-D) (effects of genotype Fs2, 25 ≤ 1.14 15.78, ps > 0.05). Note, one Foxp1 
heterozygous mouse performed very few presses, which skewed the ISI data on day 3. These data 
indicate that the overall organisation of pressing is intact in Foxp1 heterozygous and Foxp1 
homozygous mice and that any deficits would have to be in the timing of pressing. 
 
 
Figure 3.9. Operant lever-pressing. Lever-press sequence analyses during self-paced training sequence. Number of lever 
presses in a sequence (A), sequence duration (B), inter-sequence interval (C) and mean within-sequence inter-press intervals 
(IPIs) (D) of Controls (black) (n=11), Foxp1 heterozygous (light blue) (n=9) and Foxp1 homozygous (red) (n=8) through the 
task. Data shown are represented as mean ± SEM.  
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In order to look in detail at the microstructure of lever-pressing behaviour, inter-press intervals (IPIs) 
were divided into three types - rapid (no event between presses), check (presses separated by head 
entry into the food magazine) and consumption (presses separated by head entry and licking). The 
median and median absolute deviation (MAD) / median (a measure of variability) of these 
distributions for each of the genotypes were calculated. Again, no differences were observed between 
striatal-specific Foxp1 knockdown mice and Controls (Figure 3.10) (effects of genotype Fs2, 25 ≤ 1.52 
15.78, ps > 0.05), indicating that the learning and performance of fine motor-skills in these animals is 
normal. 
 
 
Figure 3.10. Operant lever-pressing. Average median (A-C) and MAD/median (D-F) values of rapid (A and D), check (B 
and E) and consumption (C and F) IPIs groups of Controls (black) (n=11), Foxp1 heterozygous (light blue) (n=9) and Foxp1 
homozygous (red) (n=8) through the task. Data shown are represented as mean ± SEM. 
 
3.7. Striatal-specific Foxp1 knockdown show normal sociability and preference for social novelty 
To evaluate social interaction in the striatal-specific Foxp1 knockdown mice, a 3-chamber task was 
performed to investigate the sociability and the preference for social novelty (Moy et al. 2004). The 
subjects first had to choose between an unfamiliar mouse and an empty cup, and secondly between the 
now familiar mouse and a new unfamiliar mouse (see Materials and Methods 2.10 for details). 
 
 
Figure 3.11. Sociability and preference for social novelty. Distribution for duration of time spent in each chamber for the 
sociability and preference for novelty tests of Controls (black) (n=18), Foxp1 heterozygous (light blue) (n=15) and Foxp1 
homozygous (red) (n=15). 
 
In the first part of the task, all genotypes preferred the unfamiliar mouse to the empty cup (Figure 3.11 
A), suggesting that their sociability is normal. For the second part of the task, Foxp1 homozygous 
mice showed a preference for the unfamiliar mouse over the familiar mouse but this preference was 
less clear in Foxp1 heterozygous mice and Controls (Figure 3.11 B). Taken together these data suggest 
that striatal-specific Foxp1 knockdown mice do not have significant deficits in sociability or 
preference for social novelty. 
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3.8. Generation of mice heterozygous for Foxp1 and Foxp2 globally  
Foxp1 disruption in the striatum using the Rgs9-Cre line led to a partial knockdown rather than a 
knockout of the Foxp1 protein, which made some experiments difficult to interpret. Therefore a 
different strategy was used to investigate Foxp1 function and potentially cooperative functions with 
Foxp2. Global Foxp1 heterozygous mice and global Foxp2 heterozygous mice were crossed to give 
offspring of four genotypes (Figure 2.5). Considering equal feeding and maternal care, mouse pups 
body weight was measured at postnatal days 6, 8, 10, 12, 15, 18 and 21 from Controls, Het1, Het2 and 
dHet mice (Figure 3.12). There was a tendency for dHet pups to show reduced body weight compared 
to controls (time x genotype interaction F18, 168 = 2.16, p < 0.05; effect of genotype F3, 28 = 2.32, p > 
0.05) but this only reached significance on day 21. 
 
 
Figure 3.12. Weight development. Weight development of Controls (n=8), Het1 mice (n=9) and Het2 mice (n=8) and dhet 
mice (n=7) between postnatal days 6 and 21. Data shown are represented as mean ± SEM. *p < 0.05. 
 
3.9. Mice heterozygous for Foxp1 and Foxp2 show pronounced motor-skill learning deficits 
Mice from the Foxp1 and Foxp2 heterozygous intercross were also tested with the same conditions as 
striatal-specific Foxp1 knockdown mice on the accelerating rotarod to investigate motor-skill learning 
(Figure 3.13). 
 
Figure 3.13. Latency to fall. Latency to fall (A) and average of the latency to fall (B) of Controls (n=10), Het1 (n=10), Het2 
(n=13) and dHet (n=9) mice during training on the accelerating rotarod. Adult mice with more than 10 weeks or 2 months of 
age received a training of 10 trials a day for 5 consecutive days. Data shown are represented as mean ± SEM. *p < 0.05. 
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dHet mice fell from the rotarod significantly earlier than Controls on days 2-5 (time x genotype 
interaction F12, 152 = 2.30, p < 0.05; effect of genotype F3, 38 = 6.37, p < 0.05). Their learning rate also 
appeared to be perturbed but was not significantly different from that of Controls (Figure 3.14). This 
was probably due to the big increase in latency to fall seen in Controls on day 2. In addition, Het2 also 
showed a significantly reduced latency to fall compared to Controls on day 5, which is consistent with 
previous data (French et al. 2012). 
 
 
Figure 3.14. Learning rate. Rate of learning in Controls (n=10), Het1 (n=10), Het2 (n=13) and dHet (n=9) mice during 
training on the accelerating rotarod. Data shown are represented as mean ± SEM. 
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4. Discussion 
 
It is known that ASDs are linked with the Foxp1 gene, which is broadly expressed in the striatum, a 
brain region increasingly being reported to be dysfunctional in ASDs (Fuccillo et al. 2016). Therefore 
a conditional approach was used to selectively knockdown Foxp1 from striatum, a critical area 
involved in motor-sequence learning, automatisation of behaviour and social interaction. 
Homozygous, heterozygous and control subjects for the knockdown of Foxp1 gene in the striatum 
were subjected to behavioural tasks to investigate an overall assessment of motor coordination and 
balance, an evaluation of motor-skill learning, the learning and performance of novel motor-sequences 
and the sociability and preference for social novelty. 
 
4.1. Level of protein loss in striatal-specific Foxp1 knockdown mice 
Foxp1 protein levels in striatum and cortex (control where Foxp1 expression was expected) were 
quantified by western blot techniques. No differences were found between Foxp1 homozygous mice 
and Controls in either brain region suggesting that striatal-specific Foxp1 disruption had not occurred. 
However the high concentrations of primary Foxp1 antibody used, its specificity, and the long 
exposure times required to visualise bands continue an issue to pay attention. It was therefore decided 
to move to a histological approach, where the antibody performed better, and the results are more 
reliable. Immunohistochemistry showed substantial deletion in dorsal striatum and appreciable 
deletion in ventral striatum of Foxp1 homozygous mice, indicating that a knockdown rather than a 
knockout of Foxp1 had occurred. 
This result was surprising, since the Rgs9-Cre line has previously been successfully used to disrupt the 
NMDA receptor and Foxp2 in the striatum (Jin et al. 2010; French personal communication). It seems 
that the Rgs9 promoter does not drive Cre expression in all MSNs and Foxp1 is expressed in the vast 
majority of these cells, resulting in a partial knockdown. There are two other Cre lines commonly used 
with conditional mice to generate striatal-specific disruption of genes. The Dlx5/6-Cre line was 
previously crossed with Foxp2 conditional mice resulting in only modest protein knockdown, 
probably because Cre in this line in expressed predominantly in interneurons (French personal 
communication). A further line, GPR88-Cre, has also been used to disrupt the NMDA receptor in the 
striatum and is an option to pursue (Koralek et al. 2012). An alternative approach would be to 
stereotaxically inject Cre-expressing virus into the dorsal or ventral striatum of adult Foxp1 
conditional mice. With this approach Foxp1 protein would be present during development, so results 
would have to be interpreted accordingly. 
 
4.2. Motor-skill learning and performance are relatively normal in mice with Foxp1 disruptions 
Striatal-specific Foxp1 knockdown mice showed normal bodyweight development, although the 
Foxp1 gene is crucial in development and differentiation of several organs, and could therefore be 
used for tasks that assess motor-skill learning and performance. On the accelerating rotarod, Foxp1 
homozygous mice showed a reduced latency to fall compared with Controls in the latter part of day 1.  
In general, these mice seemed to perform well at the beginning of training but their performance then 
decreased, before recovering at the start of day 2. This effect was caused by several mice rather than 
one outlier (the SEM did not increase). This result would need to be confirmed in a second cohort of 
animals. It should also be noted that there was no difference in latency to fall from the rotarod between 
global Foxp1 heterozygous animals and Controls. 
Striatal-specific Foxp1 knockdown animals also performed press-sequences similarly to Controls. 
There were no differences in the organisation of press-sequences or the speed at which they were 
performed, which could indicate a deficit in fine motor-skills. Furthermore, the variability of pressing 
was normal suggesting that automatisation of motor-skills is not altered.  
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The ability to learn novel motor-skills is linked to the dorsal striatum (Costa et al. 2004), where Foxp1 
deletion was substantial in striatal-specific Foxp1 knockdown mice. Taken together, data from the 
accelerating rotarod and the lever-pressing task suggest that Foxp1 does not play a major role in 
motor-skill learning, except perhaps at early stages. Motor-skill learning deficits have not been 
reported, and have in some cases not been tested for, in other Foxp1 mouse models (Bacon et al. 2015; 
Araújo et al. 2015) but gross motor delay has been reported in a subset of people carrying Foxp1 
disruptions (Bacon et al. 2012). 
 
4.3. Foxp1 and social behaviour 
Deficits in social interaction are primary diagnostic indicators of autism. Nevertheless, no differences 
were seen in sociability or preference for social novelty in striatal-specific Foxp1 knockdown mice 
compared to Controls in the 3-chamber task. However, these data are difficult to interpret because 
there was significant Foxp1 expression in the ventral striatum of these animals, a region known to be 
important for social motivation and reward. Interestingly, preliminary data suggest that global Foxp1 
heterozygous animals also behave normally when performing the 3-chamber task (Ghita, L. personal 
communication). There are alternative behavioural tasks available to examine other aspects of social 
behaviour in mice, for example direct interaction, tube test, water T-maze or vocalisations but it 
should also be kept in mind that studies in mice may not be able to entirely replicate complex human 
social behaviour.   
 
4.4. Potential Foxp1 and Foxp2 cooperative functions 
Recent studies of FoxP family proteins in humans and rodents have significantly increased the 
understanding of their neuronal functions. Although disruptions of Foxp1 and Foxp2 cause autism 
spectrum disorders and a rare speech and language disorder respectively, these proteins are known to 
interact and may function cooperatively in brain regions where they are co-expressed such as the 
striatum. To investigate this mice with global heterozygous deletion of Foxp1 and global heterozygous 
deletion of Foxp2 (Foxp1-∆11-12 and Foxp2-S321X lines) were intercrossed. Clear differences are 
seen in dHet mice compared to controls, Het1 and Het2 animals on the accelerating rotarod task, not 
only in the latency to fall but also in the learning rate. Although these data are consistent with a 
cooperative role for Foxp1 and Foxp2 in motor-skill learning, at this stage it is not possible dismiss the 
possibility that we are affecting two pathways that independently contribute to motor-skill learning. 
 
4.5. Future perspectives 
Although Foxp1 deletion was not as expected initially, in which mice revealed a knockdown of Foxp1 
rather than a knockout, the striatal-specific Foxp1 knockdown line allows to observe some interesting 
characteristics, which should be studied with different mouse models. 
Deleting the Foxp1 gene in adulthood with viral injections in the nucleus accumbens, a region related 
to rewarding experiences and motivation, has been doing to investigate social behaviour in these 
animals. 
The analyses of motor and social behaviour in offspring from the Foxp1-∆11-12/+ and Foxp2-
S321X/+ with a view to investigating functional cooperation between Foxp1 and Foxp2 in the future 
also has been performing. 
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